Arbutus Biopharma Corp.
(NASDAQ : ABUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-3.16%282.201.4%$837.91m
AMGNAmgen, Inc.
-0.40%220.421.3%$493.04m
CELGCelgene Corp.
0.47%110.521.3%$451.09m
GILDGilead Sciences, Inc.
-1.63%63.271.0%$378.33m
ILMNIllumina, Inc.
0.73%297.893.5%$307.55m
VRTXVertex Pharmaceuticals, Inc.
1.19%206.281.9%$293.53m
REGNRegeneron Pharmaceuticals, Inc.
-0.41%346.992.6%$260.97m
EXASEXACT Sciences Corp.
-1.52%78.7024.0%$193.16m
ALXNAlexion Pharmaceuticals, Inc.
-2.18%107.062.0%$186.03m
SGENSeattle Genetics, Inc.
1.40%112.196.1%$128.29m
BMRNBioMarin Pharmaceutical, Inc.
0.36%76.154.3%$111.11m
SRPTSarepta Therapeutics, Inc.
2.14%102.0914.6%$109.17m
AAgilent Technologies, Inc.
0.06%77.101.6%$100.09m
MRTXMirati Therapeutics, Inc.
-2.95%101.252.3%$86.46m
NBIXNeurocrine Biosciences, Inc.
-0.93%110.375.0%$83.46m

Company Profile

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.